ArticleHuman mutation2026
Peripheral Immune and Metabolic Dysregulation in Migraine, Ménière's Disease, and Vestibular Migraine: A Single-Cell Atlas Study.
Article in Human mutation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Migraine immune cell gene targets and their relationship to psychiatric disorders.The journal of headache and pain · 2026Article
- Peripheral Immune and Metabolic Dysregulation in Migraine, Ménière's Disease, and Vestibular Migraine: A Single-Cell Atlas Study.Human mutation · 2026Article
- Comorbidities and impact on quality of life in patients with Ménière's disease: a single-center cross-sectional study.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Migraine (MI), Ménière's disease (MD), and vestibular migraine (VM) share significant clinical and pathological similarities, particularly their link to neurological dysfunction and immune cell activity, though mechanisms remain poorly understood. Methods: We utilized a single-cell RNA sequencing dataset of peripheral blood mononuclear cells from eight patients with MD, five patients with MI, five patients with VM, and six healthy controls. A cross-disease cell atlas was constructed via cellular heterogeneity and dynamic cell abundance analysis. Further studies analyzed metabolic heterogeneity and performed differential expression analysis across all groups. The core regulatory pathways were identified using gene set enrichment and pathway analyses. Additionally, herbal and compound screenings related to targets in MI were performed. Pseudotime analysis was then employed to infer the evolutionary trajectories, identifying key genes associated with differentiation. Results: We identified 42,198 cells grouped into 16 clusters and classified into five cell types: T cells, B cells, dendritic cells, natural killer cells, and monocytes. Among these, T cell abundance significantly increased, whereas monocytes were essential for metabolic reprogramming. Notably, the upregulated MAPK signaling pathway was identified as the core regulatory pathway. A total of 1571 interaction pairs were screened between matched targets for herbs and compounds. T cell trajectory analysis revealed two differentiation pathways originating from CD8 Conclusions: This study identified distinct immune cell patterns in MI, MD, and VM, with notable T cell imbalances.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.